Reduning injection for chikungunya fever
Part of Infections clinical trials.
This study tests an herbal injection called Reduning to see if it safely reduces fever and relieves pain from chikungunya, a mosquito-borne virus. It may help you feel better faster if you're in the early stage of the illness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chikungunya fever (fever from a mosquito-borne virus).
- Your fever started within the last 48 hours and your temperature is at least 100.4°F (38°C).
- You have at least one symptom like headache, muscle pain, joint pain, joint swelling, rash, or nausea, and it's moderate or severe.
- You are between 18 and 70 years old.
- You haven't been diagnosed with another infection like dengue, flu, or COVID-19.
- You don't have chronic arthritis, a weakened immune system, severe heart/liver/kidney disease, or obesity (BMI 30 or higher).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well Chinese medicine, Western medicine, or a mix of both works for people with chikungunya fever. It's a real-world study, meaning it follows what happens in everyday medical care, to see which approach helps patients feel better faster.
This study tests an experimental vaccine designed to protect against chikungunya, a mosquito-borne virus that causes fever and joint pain. The trial will evaluate the vaccine's safety and immune response in healthy adults.
This study tests a new vaccine to protect against chikungunya virus, a disease spread by mosquitoes that causes fever and joint pain. The study measures how well your immune system responds to the vaccine and tracks any side effects.
This trial tests whether giving the dengue and chikungunya vaccines together is as safe and effective as giving them separately. If you are a healthy adult, you may be able to help find a more convenient way to protect against these diseases.
This trial tests an experimental chikungunya vaccine (made from a virus-like particle) to see if it prevents the disease. It is for healthy teens and adults who have not had chikungunya before.
This study looks at how well the chikungunya vaccine works in real life, how safe it is, and how the body's immune system responds. It is for adults who are eligible for the vaccine according to French health guidelines.
Hear when a new Chikungunya Fever trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.